BioLineRx Announces Initiation of Phase 1b/2 Trial of BL-8040 in Pancreatic Cancer under Immunotherapy Collaboration

Combination trial of BL-8040 and atezolizumab are part of initiative for the development of novel cancer immunotherapy combinations